MedPath

EO-S100850

Generic Name
EO-S100850
Clinical Trials
Related News

Study of Inupadenant (EOS100850) With Chemotherapy as Second Line Treatment for Nonsquamous Non-small Cell Lung Cancer

Phase 2
Recruiting
Conditions
Locally Advanced NSCLC - Non-Small Cell Lung Cancer
Metastatic NSCLC - Non-Small Cell Lung Cancer
Interventions
Drug: Placebo
First Posted Date
2022-06-03
Last Posted Date
2024-06-24
Lead Sponsor
iTeos Belgium SA
Target Recruit Count
186
Registration Number
NCT05403385
Locations
πŸ‡ΊπŸ‡Έ

Highlands Oncology Group, Fayetteville, Arkansas, United States

πŸ‡ΊπŸ‡Έ

Innovative Clinical Research Institute (ICRI), Whittier, California, United States

πŸ‡ΊπŸ‡Έ

Mid-Florida Hematology & Oncology Centers, PA, Orange City, Florida, United States

and more 64 locations

New Formulation Study of Inupadenant (EOS100850) in Patients With Cancer

Phase 1
Recruiting
Conditions
Solid Tumor, Adult
Interventions
First Posted Date
2021-11-11
Last Posted Date
2023-05-03
Lead Sponsor
iTeos Therapeutics
Target Recruit Count
64
Registration Number
NCT05117177
Locations
πŸ‡§πŸ‡ͺ

GZA Ziekenhuizen, Wilrijk, Antwerpen, Belgium

πŸ‡§πŸ‡ͺ

Institut Jules Bordet, Anderlecht, Belgium

πŸ‡§πŸ‡ͺ

Cliniques Universitaires St-Luc, Brussels, Belgium

and more 2 locations

Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors

Phase 1
Active, not recruiting
Conditions
Head and Neck Cancer
Advanced Cancer
Lung Cancer
Melanoma
Interventions
Drug: SOC chemotherapies
First Posted Date
2021-09-29
Last Posted Date
2024-06-21
Lead Sponsor
iTeos Belgium SA
Target Recruit Count
153
Registration Number
NCT05060432
Locations
πŸ‡§πŸ‡ͺ

Cliniques universitaires St Luc-UCL, Brussels, Belgium

πŸ‡§πŸ‡ͺ

Jessa Ziekenhuis, Hasselt, Belgium

πŸ‡§πŸ‡ͺ

UZ Leuven, Leuven, Belgium

and more 39 locations

First-in-Human Study of EOS100850 in Patients With Cancer

Phase 1
Active, not recruiting
Conditions
Solid Tumor, Adult
Interventions
Drug: Chemotherapy
First Posted Date
2019-03-14
Last Posted Date
2023-12-27
Lead Sponsor
iTeos Therapeutics
Target Recruit Count
119
Registration Number
NCT03873883
Locations
πŸ‡«πŸ‡·

Centre de Lutte Contre le Cancer - Institut de Cancerologie de l'Ouest - Rene Gauducheau, Saint-Herblain, France

πŸ‡ΊπŸ‡Έ

Karmanos Cancer Institute, Michigan Center, Michigan, United States

πŸ‡ΊπŸ‡Έ

John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, New Jersey, United States

and more 16 locations
Β© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy